Correlation Between Neuropace and Cooper Companies,

Can any of the company-specific risk be diversified away by investing in both Neuropace and Cooper Companies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Cooper Companies, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuropace and The Cooper Companies,, you can compare the effects of market volatilities on Neuropace and Cooper Companies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Cooper Companies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Cooper Companies,.

Diversification Opportunities for Neuropace and Cooper Companies,

-0.71

Correlation Coefficient

Neuropace  Cooper Companies,

Pay attention - limited upside

The 3 months correlation between Neuropace and Cooper is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and The Cooper Companies, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cooper Companies, and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Cooper Companies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cooper Companies, has no effect on the direction of Neuropace i.e., Neuropace and Cooper Companies, go up and down completely randomly.

Pair Corralation between Neuropace and Cooper Companies,

Given the investment horizon of 90 days Neuropace is expected to generate 2.84 times more return on investment than Cooper Companies,. However, Neuropace is 2.84 times more volatile than The Cooper Companies,. It trades about 0.26 of its potential returns per unit of risk. The Cooper Companies, is currently generating about -0.15 per unit of risk. If you would invest  898.00  in Neuropace on September 16, 2024 and sell it today you would earn a total of  205.00  from holding Neuropace or generate 22.83% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Neuropace  vs.  The Cooper Companies,

Neuropace

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Cooper Companies,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days The Cooper Companies, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Neuropace and Cooper Companies,

The main advantage of trading using opposite Neuropace and Cooper Companies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Cooper Companies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cooper Companies, will offset losses from the drop in Cooper Companies,'s long position.

The idea behind Neuropace and The Cooper Companies, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.